Physiologically Based Pharmacokinetic Modeling in Patients With Hepatic Impairment: Are Changes in Bosutinib Exposure Profiles Driven by Altered Absorption or Distribution?
CPT: Pharmacometrics & Systems Pharmacology · 2026
DOI: 10.1002/psp4.70179 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2026. Verfasst von Chieko Muto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Pfizer R&D Japan, Tokyo, Japan. Hauptthemen laut MEDLINE: Aniline Compounds, Nitriles, Quinolines, Models, Biological. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Bosutinib is an orally available Src/Abl tyrosine kinase inhibitor and has been approved for the treatment of patients with Ph + chronic myelogenous leukemia. Bosutinib is a substrate of P‐glycoprotein (P‐gp) in vitro and is predominantly metabolized by CYP3A4 in humans with minimal urinary excretion. We present our perspective on using physiologically based pharmacokinetic modeling to understand the atypical changes in oral exposure of bosutinib, a CYP3A and P‐gp substrate, in hepatic impairment patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology, Pfizer R&D Japan, Tokyo, Japan.
- Simcyp Division, Certara UK Limited, Sheffield, UK.
ORCID-Profile: Chieko Muto, Shinji Yamazaki
Zitieren
APA
Muto, C., Jones, H. M., & Yamazaki, S. (2026). Physiologically Based Pharmacokinetic Modeling in Patients With Hepatic Impairment: Are Changes in Bosutinib Exposure Profiles Driven by Altered Absorption or Distribution?. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70179
Vancouver
Muto C, Jones HM, Yamazaki S. Physiologically Based Pharmacokinetic Modeling in Patients With Hepatic Impairment: Are Changes in Bosutinib Exposure Profiles Driven by Altered Absorption or Distribution?. CPT: Pharmacometrics & Systems Pharmacology. 2026. doi:10.1002/psp4.70179
BibTeX
@article{Muto2026,
author = {Muto, Chieko and Jones, Hannah M and Yamazaki, Shinji},
title = {Physiologically Based Pharmacokinetic Modeling in Patients With Hepatic Impairment: Are Changes in Bosutinib Exposure Profiles Driven by Altered Absorption or Distribution?},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2026},
doi = {10.1002/psp4.70179}
}
EUVIMED